Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diphenhydramine and Melatonin for Postoperative Sleep Quality
NCT03968939Phase 4Completed
- Start
- Oct 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diphenhydramine and melatonin in Postoperative sleep disturbance (PSD) (3 arms). Primary endpoints: Epworth Sleepiness Scale at 12 weeks, Pittsburgh Sleep Quality Index at 12 weeks and 1 more. Started Oct 2019; status: completed.
02
Drugs
diphenhydraminemelatonin
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on NCT03968939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03968939.